Lupin’s Diabetes Drug Sales Leads Company To Meet Profit Estimates
Also in the news, the health and safety device maker Halma buys a company known for making sensors in an effort to expand its U.S. footprint.
Reuters:
Lupin Expects Diabetes Drug Sales To Lift Q4 Profit
Lupin Ltd, India's third-largest drugmaker, reported a quarterly profit that met estimates as strong sales in its local market help offset weakness in the United States, and the company said it expects fourth-quarter earnings to improve. (Siddiqui, 2/5)
Reuters:
Halma Buys Healthcare Sensors Maker CenTrak For About $140M
Halma Plc, a health and safety device maker, said it had bought CenTrak Inc, a privately owned maker of sensors, for about $140 million (95.9 million pounds), expanding its footprint in the U.S. healthcare market. Newtown, Pennsylvania-based CenTrak's technology allows for real-time monitoring of patient, staff, medical equipment, and hygiene compliance and temperature conditions. (2/5)
